India to add more AIDS, TB drugs in essential medicines list: Sources MUMBAI: India is likely to add more HIV/AIDS and tuberculosis drugs to its list of essential medicines that are subject to price caps, people directly involved in the process said, in a move to improve affordability of drugs to treat the deadly diseases. All the drugs on the ... Read More »
Yearly Archives: 2015
A Pond Full of Milk
A Pond Full of Milk : Once there was a king who told some of his workers to dig a pond. Once the pond was dug, the king made an announcement to his people saying that one person from each household has to bring a glass of milk during the night and pour it into the pond. So, the pond ... Read More »
12 of top 25 pharma shares rally over 100% in FY15
12 of top 25 pharma shares rally over 100% in FY15 Fiscal 2014-15 (FY15) has turned out to be a good year for pharmaceutical companies with nearly half of the top 25 pharma stocks becoming multi-baggers during the year. As many as 12 out of top 25 most valued pharmaceutical firms have seen price appreciation of more than 100% during ... Read More »
Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group
Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group Novartis announced today that it is stepping up its efforts to harness the body’s immune system to combat cancer. The company has entered into a major multiyear alliance with Aduro Biotech that is focused on the discovery and development of next generation cancer immunotherapies ... Read More »
Grey Goose and Gander
Grey Goose and Gander Once upon a time, there was a peaceful kingdom. The king heard rumors that barbarians were going to attack his castle soon. So he called his twofavorite pets – the huge grey goose and gander. “My dear goose and gander, our kingdom is in danger. Take my daughter to a safe place on top of the ... Read More »
VIVAN’s CSR
VIVAN’s CSR VIVAN is firm in its commitment to social responsibility and considers Human and Social Development as an integral part of our working process, aiming to make a difference in people’s lives. We deliver it with unstilted support from each individual in the Organization, which is a motivational factor at higher end of Human needs for each individual, that ... Read More »
US FDA approves Semler Scientific’s next generation PAD testing system
US FDA approves Semler Scientific’s next generation PAD testing system The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Semler Scientific’s next generation peripheral artery disease (PAD) testing system. The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was ... Read More »
THE BRICK
THE BRICK A young and successful executive was traveling down a neighborhood street, going a bit too fast in his new Jaguar. He was watching for kids darting out from between parked cars and slowed down when he thought he saw something. As his car passed, no children appeared. Instead, a brick smashed into the Jag’s side door! He slammed ... Read More »
GSK becomes partner in new global fund to accelerate dementia research
GSK becomes partner in new global fund to accelerate dementia research GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100m, brings together leading pharmaceutical companies, the UK ... Read More »
Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics
Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics NEW DELHI: Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics, taking its holding in the company to 100 per cent. Lupin had earlier acquired ... Read More »